Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human VAP1 ELISA Kit (AC2899)
Cat.#: ASET-1488
Specifications
Description Human VAP1 ELISA Kit allows for the in vitro quantitative determination of human VAP1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.938 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.563-100 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2218 Human POMT1 ELISA Kit (AC3629) Quantitative inquiry ASET-1571 Human VCAM1 ELISA Kit (AC2982) Quantitative inquiry ASET-2126 Human LAMC2 ELISA Kit (AC3537) Quantitative inquiry ASET-1988 Rat Pituitary Adenylate Cyclase-Activating Polypeptide ELISA Kit (AC3399) Quantitative inquiry ASET-2404 Porcine TSH ELISA Kit (AC3815) Quantitative inquiry ASET-2441 Camel Insulin ELISA Kit (AC3852) Quantitative inquiry ASET-2155 Rat MAdCAM1 ELISA Kit (AC3566) Quantitative inquiry ASET-2454 Human LAR ELISA Kit (AC3865) Quantitative inquiry ASET-1405 Human Thimet Oligopeptidase ELISA Kit (AC2816) Quantitative inquiry ASET-1734 Mouse GDF11 ELISA Kit (AC3145) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket